James M Crawford, MD, PhD. firstname.lastname@example.org. Executive Director and Senior Vice President for Laboratory Services, . Northwell Health. Professor and Chair, Pathology/Lab Medicine. Hofstra Northwell School of Medicine. ID: 647891
DownloadNote - The PPT/PDF document "Moving to Clinical Lab 2.0" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Moving to Clinical Lab 2.0James M Crawford, MD, PhDjcrawford1@northwell.eduExecutive Director and Senior Vice President for Laboratory Services, Northwell HealthProfessor and Chair, Pathology/Lab MedicineHofstra Northwell School of MedicineManhasset, NY
Deliver more Value!
Get Paid More Dollars!Slide2
Disclosures2ClaraPath (start up from Cold Spring Harbor Laboratories)*2015: Technical Advisory CommitteeNorthwell Health Genomics Alliance (with OPKO Health)2015: President of LLC*Technology TransferSlide3
What is “Clinical Lab 2.0”3Transactional Lab Data → Integrative InformationReactive: Order/Result → Proactive: Need/InformationLab = Commodity → Lab = Essential system assetTechnical experts only → SME on Health Care deliveryWe don’t look at our own data → We are the experts on what our data mean Identification of Risk Escalation of Health Care Gaps-in-Care Outcomes (or not)
We can help drive financial health of systemSlide4
Who are our Stakeholders?4Those who pay for our information: Payers Health system Employers Those who make health care decisions: Providers Consumers“Value” is what someone is willing to pay for.Listen to their needs.
Are we meeting their needs?
“Clinical Lab 2.0” is Leadership, not Followship5Slide6
What are we responding to?6DownsideUnder-appreciation by our StakeholdersUnder-utilization of our expertiseRisk of not controlling our destinyUpsideExtraordinary opportunity to provide better health careUnrealized opportunity to support better financial outcomes for our Stakeholders*ABN, Advanced Beneficiary NoticeSlide7
Objectives of this Workshop7To identify measures of Success for a “2.0” clinical laboratoryTo understand the strategies for getting thereTo learn tactical approaches from review of examplesTo share in lessons learnedSlide8
9“HERE”“THERE”Be IntrusiveBe InsistentBe Creative
Learn new SkillsBuild new Teams
“Innovation” in detail10Inpatient: AKI, antibiotic stewardship, sepsis bundles….Outpatient: CKD, diabetes, anti-coagulation….“Innovation” at global level
Disease Management teams
Where is the Opportunity?
Not your “3%” – the
Impact of Lab on the Total Health Care Spend
Impact of Lab on the Total Revenue CycleSlide11
Clinical Lab 1.0Slide12
Clinical Lab 2.0Slide13
The Structure of Today’s Workshop13Khosrow Shotorbani: Why is Clinical Lab 2.0 different?Tarush Kothari, MD, MPH: Success story with AKIIlan Rubinfeld, MD: Health System CMO perspectiveMonique Dodd, DPharm/ Building the Value Statements Kathleen Swanson, MS, RPhAron
Seidman Changing IT infrastructure
Informatics PanelOpen Q&A SessionSlide14
Today's Top Docs